FDA Investigator Don A Leeseberg
Don A Leeseberg has conducted inspections on 827 sites in 5 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
827
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Guam,
Italy,
Northern Mariana Islands,
American Samoa
FDA Investigators that have inspected at least one site in common with Don A Leeseberg:
Abraham M Maekele,
Adam S Freeman,
Akbar J Zaidi,
Allison E Sincek,
Andrew Saunders,
Angela Mock,
Beverly A Thomas,
Blondell W Johnson,
Bonnie E Pierson,
Carl A Huffman, III,
Charles L Larson,
Charles M Spyr,
Christopher B May,
Christopher C Wilcox,
Comyar Shoghi,
Craig A Garmendia,
Dawn M Mccabe,
Deborah M Mcgee,
Debra L Curtis,
Delkis J Caycedo,
Dennis R Butcher,
Dennis R Hock,
Dolores Harper,
Dustin R Abaonza,
Elaine G Stewart,
Elisa M Fleming,
Elizabeth A Laudig,
Emir Galevi,
Emmanuel A Dimaano, Jr,
Francis A Guidry,
Gabriel M Guevarra,
Gary L Zaharek,
George T Allen, Jr,
Gerald T O'connor,
Herbert E Arden,
Iris C Macinnes,
J Elkins,
Jaclyn N Munsch,
Jacqueline M Bowling,
James E Frye,
James H Robinson,
James R Montero,
James R Wormuth,
Jeanne F Broderick,
Jeffrey A Sincek,
Jeffrey R Wooley,
Jocelyn C Turner,
Jocelyn T Ramos,
Johann M Fitch,
John A Hall,
John D Mays,
Jorge E Martinez,
Joshua J Silvestri,
Joshua S Hoeh,
Ka L Wong,
Karen M Rodriguez,
Karen R Smallwood,
Kelly N Kerr,
Lauren E Swantko,
Laurissa S Flowers,
LCDR Matthew J Morrison,
Leo J Lagrotte,
Leonard Pesetsky,
Lori A Carr,
Lydia S Chan,
Maida Henesian (NMI),
Margaret A Foster,
Maricelys Mercado,
Michael C Ireland,
Michael E Cimaglio,
Michael J Leal,
Michelle Hawkins,
Minerva Rogers,
Minh D Phan,
Myra K Casey,
Nicholas Z Lu,
Nikisha M Bolden,
Paul A Licata,
Paula J Bretz,
Peter R Lenahan,
Rachel T Evans,
Randall F Albright,
Randy V Bong,
Raymond W Brullo,
Reggie D Cope,
Richard L Mallonee,
Ricki A Chase,
Rita F Larocca Mahoney,
Robert E Davis,
Robert G Antonsen, Jr,
Roy Baby,
Rterry Bolen,
Saijal P Naik,
Samuel L Murray,
Sarah L Clark,
Scotty L Hargrave,
Sergio Chavez (NMI),
Shelley H Beausoleil,
Stacy M Below,
Stephanie Mangigian, MS/OSH, RN,
Susan M Miller,
Suzie L Kent,
Tania E Vizcaino,
Tania Y Hall,
Teena H Aiken,
Terri L Jones,
Thai T Duong,
Thomas D Clarida,
Timothy C Grome,
Timothy P Lafave,
Tina A Desorcy,
Toni S Sturgis,
Travis E Chapman,
Vien Q Le,
Vivian Garcia,
William D Bassett, Jr,
Yvonne C Wilkes,
Zachary L Miller
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more